Impetigo epidemiology and demographics

Jump to navigation Jump to search

Impetigo Microchapters


Patient Information


Historical Perspective




Differentiating Impetigo from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

X Ray




Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Impetigo epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Impetigo epidemiology and demographics

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Impetigo epidemiology and demographics

CDC on Impetigo epidemiology and demographics

Impetigo epidemiology and demographics in the news

Blogs on Impetigo epidemiology and demographics

Directions to Hospitals Treating Impetigo

Risk calculators and risk factors for Impetigo epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]


In 2010, 140 million people suffered from impetigo. Impetigo is more common among children. Impetigo is more prevalent in tropical and pacific countries.[1][2][3]

Epidemiology and Demographics


  • In 2010, 140 million people suffered from impetigo.[3]


  • The prevalence of impetigo in Australian Aboriginal communities is 49%.[2]
  • The prevalence of impetigo in Solomon Islands is 43%.[4]
  • Impetigo is more prevalent in tropical and pacific countries.[1][2]
  • In 2006-2007, 25.6% school going children and 12.2% infants had active impetigo in Fiji.[1]


  • Impetigo is more common among young children between age 2 to 5. Particularly those who attend school or daycare centers.[5][6][1]
  • A study showed that almost 69% of children below the age of 16 were affected by impetigo.[2]
  • Non-bullous impetigo is rare in children under 2 years.[7]


  • The distribution of impetigo is not effected by gender of the patient.


  • Impetigo is very common in Australian Aboriginal communities and Solomon Islands.[2]


  1. 1.0 1.1 1.2 1.3 "High Burden of Impetigo and Scabies in a Tropical Country".
  2. 2.0 2.1 2.2 2.3 2.4 Romani L, Steer AC, Whitfeld MJ, Kaldor JM (2015). "Prevalence of scabies and impetigo worldwide: a systematic review". Lancet Infect Dis. 15 (8): 960–7. doi:10.1016/S1473-3099(15)00132-2. PMID 26088526.
  3. 3.0 3.1 Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M; et al. (2012). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID 23245607.
  4. Eason RJ, Tasman-Jones T (1985). "Resurgent yaws and other skin diseases in the Western Province of the Solomon Islands". P N G Med J. 28 (4): 247–50. PMID 2940770.
  5. Hartman-Adams H, Banvard C, Juckett G (2014). "Impetigo: diagnosis and treatment". Am Fam Physician. 90 (4): 229–35. PMID 25250996.
  6. Cohen PR (2016). "Bullous impetigo and pregnancy: Case report and review of blistering conditions in pregnancy". Dermatol Online J. 22 (4). PMID 27617460.
  7. Pereira LB (2014). "Impetigo - review". An Bras Dermatol. 89 (2): 293–9. PMC 4008061. PMID 24770507.

Template:WH Template:WS